Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial

Peer Review reports

Original Submission
28 Mar 2023	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
27 Jul 2023	Author responded	Author comments - Christelle Bouchart
Resubmission - Version 3
27 Jul 2023	Submitted	Manuscript version 3
16 Aug 2023	Author responded	Author comments - Christelle Bouchart
Resubmission - Version 4
16 Aug 2023	Submitted	Manuscript version 4
Publishing
22 Aug 2023	Editorially accepted
21 Sep 2023	Article published	10.1186/s12885-023-11327-x

Back to article page